Reynoso Jamie L. 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Clover Health (CLOV) CEO Jamie L. Reynoso Sells 6,350 Shares
What Happened Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health (CLOV), reported the sale of 6,350 shares on 2026-06-15. The shares were disposed at a weighted average price of $4.61, for total proceeds of approximately $29,274. The filing indicates these sales were sell-to-cover transactions tied to tax withholding for vested restricted stock units (RSUs), not discretionary investment sales.
Key Details
- Transaction date: 2026-06-15; Form 4 filed: 2026-06-16 (appears timely; Form 4 is due within two business days).
- Shares sold: 6,350; weighted average price: $4.61; total proceeds: ~$29,274.
- Price range: $4.61 to $4.64 across multiple trades (report offers to provide per-price breakdown on request).
- Footnote: Sales were mandatory sell-to-cover to satisfy tax withholding on RSU vesting (not a voluntary sell).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
Context Sell-to-cover transactions are common when RSUs vest and are generally done to satisfy tax obligations; they do not necessarily reflect the insider’s view on the company’s prospects. Purchases are typically more informative about insider sentiment than routine tax-related sales.
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2]2026-06-15$4.61/sh−6,350$29,274→ 2,843,571 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.